In this proof-of concept study, CureHeart PI Eric Olson and his team identify an adenine base editor and single-guide RNA system which can efficiently correct the genetic alteration which leads to hypertrophic cardiomyopathy (HCM). This exciting study demonstrates the potential of base editing to treated inherited cardiac diseases, which will form the basis of much of CureHeart's work over the coming years.
Read the full article here.
